Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3034)
  2. Meeting Abstract (2566)
  3. Review (138)
  4. Editorial (107)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5787)
  2. Department of Medicine (4331)
  3. Department of Pathology and Laboratory Medicine (3081)
  4. Tow Center for Developmental Oncology (TCDO) (2648)
  5. Solid Tumor Oncology Division (2641)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2590)

More Groups

People
  1. Marc Ladanyi (1335)
  2. Ross Levine (787)
  3. David Solit (782)
  4. Michael Berger (772)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (428)

More People

Years
  1. 2025 (191)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (650)
  2. Blood (517)
  3. Cancer Research (413)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (270)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (877)
  2. Nature Publishing Group (769)
  3. American Society of Clinical Oncology (718)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (409)
  6. Nature Research (314)

More Publishers

Results (6007)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Translocation carcinomas of the kidney
    Journal Article

    Argani, P.; Ladanyi, M.
    Clinics in Laboratory Medicine (2005)

    Fulltext@MSK | Save
  • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    Journal Article

    She, Qing Bai; Solit, David B.; Ye, Qing; O'reilly, Kathryn E; Lobo, Jose; Rosen, Neal
    Cancer Cell (2005)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Expression profiling of phenotypic and molecular heterogeneity in synovial sarcoma: Global transcriptional differences between SYT-SSX1 and SYT-SSX2 and use of RNAi to define transcriptional effects of SYT-SSX
    Meeting Abstract

    Saito, T.; Olshen, A. B.; Argani, P.; Ladanyi, M.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Basso, A. D.; Sawai, A.; Chapman, P.; Rosen, N.; Solit, D. B.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Activated, mutated B-raf protein kinase requires the HSP90 chaperone for folding and stability and is degraded in response to HSP90 inhibitors
    Meeting Abstract

    Grbovic, O. M.; Basso, A. D.; Friedlander, P.; Houghton, A.; Solit, D. B.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Combinatorial targeting of oncogenesis via a novel rationally designed Hsp90 inhibitor
    Meeting Abstract

    Chiosis, G.; Solit, D.; Vilenchik, M.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison
    Meeting Abstract

    Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygaidanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Valentin, G.; Delacruz, A.; Ye, Q.; Schwartz, L.; Larson, S.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Expression profiling of phenotypic and molecular heterogeneity in synovial sarcoma: Global transcriptional differences between SYT-SSX1 and SYT-SSX2 and use of RNAi to define transcriptional effects of SYT-SSX
    Meeting Abstract

    Saito, T.; Olshen, A. B.; Argani, P.; Ladanyi, M.
    FASEB Journal (2004)

    Fulltext@MSK | Save